Since kids are not small adults, as many pediatricians like to say, the FDA needs to examine data from trials done specifically with children.
Children’s bodies are still developing and react differently to a vaccine than an adult would. So as with any vaccine for kids, scientist tested different doses to determine what a child’s body can tolerate and what dose level would be protective. For younger children, Pfizer requested authorization for a 10- microgram dose; the doses used in people 12 years and older is 30 micrograms. The vaccine still requires two doses given three weeks apart.
Why a kids vaccine is needed.
Nearly 6.2 million children have tested positive for Covid-19 since the start of the pandemic. While cases have been trending downward recently, this past week alone about 131,000 more children were diagnosed with Covid 19. According to the American Academy of pediatrics.
28 million children ages 5 to 11 in the United States may soon be eligible for the Covid-19 vaccine, and plans are already underway to help them get it.
The US Food and Drug Administration’s independent vaccine advisory board will meet Tuesday to discuss whether Pfizer and BioNTech’s Covid-19 vaccine should be authorized for younger kids. If authorized, it would become the first vaccine available for younger children. Pfizer’s vaccine is already authorized for children 12 to 15 and is approved for people age 16 and older.